NRx Pharmaceuticals, Inc. (NRXPW)

Market Cap	71.07M
Revenue (ttm)	n/a
Net Income (ttm)	-33.79M
Shares Out	19.71M
EPS (ttm)	-2.35
PE Ratio	n/a
Forward PE	3.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,800
Open	0.0739
Previous Close	0.0640
Day's Range	0.0606 - 0.0739
52-Week Range	0.0395 - 0.5000
Beta	1.64
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NRXPW

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: NRXPW
• Website: https://www.nrxpharma.com